Novan Inc

NASDAQ:NOVN   3:59:57 PM EDT
0.51
0.00 (+0.16%)
Products

Novan’s Nitricil Technology Shows In Vitro Antiviral Effect Against SARS-CoV-2 In Human Airway Infection Model

Published: 10/14/2020 11:21 GMT
Novan Inc (NOVN) - Novan’s Nitricil™ Technology Shows in Vitro Antiviral Effect Against Sars-cov-2 in Human Airway Infection Model.
Novan Inc - Plans to Initiate Cmc Work to Develop Intranasal Formulation of Berdazimer Sodium for Use in Coronavirus Program.
Novan-results From in Vitro Assessment of Concentrations As Low As 0.75 Mg/ml Demonstrated Berdazimer Sodium Reduced 90% of Virus After Repeat Dosing.